Botensilimab [2408310-37-0]

TargetMol Chemicals

Botensilimab

9

2408310-37-0

Antibody

Research Use Only

Botensilimab

Botensilimab (AGEN 1181), a humanized monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4), functions as an activator of both innate and adaptive immunity. It is currently being researched for its potential application in cancer treatment [1].

3 years

-20°C

12352203